Emad Ibrahim, MD
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $82,524 of the $84,716 with a category attached, or 97.4%. Aytu Biopharma, Inc. accounts for 97.6% of it on its own, with 17 other manufacturers making up the rest. Reporting peaked in 2019 at $66,353 and has fallen 99.7% since, to $191 in 2025. Among urology clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 46 payments — averaging $1841.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Aytu Biopharma, Inc.$83K
- Endo Pharmaceuticals Inc.$610
- Coloplast$346
- Ambu Inc.$224
- Axonics, Inc.$185
- Boston Scientific$125
- plus $516 from 12 others
What the payments were for
- Speaking & faculty fees$82,52497%
- Food & beverage$2,1923%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Aytu Biopharma, Inc. | 4 | $82,710 |
| Endo Pharmaceuticals Inc. | 13 | $610 |
| Coloplast | 2 | $346 |
| Ambu Inc. | 2 | $224 |
| Axonics, Inc. | 3 | $185 |
| Boston Scientific | 5 | $125 |
| Telix Pharmaceuticals | 1 | $84 |
| Acerus Pharmaceuticals Corporation | 2 | $80 |
| Sumitomo Pharma America, Inc. | 4 | $80 |
| Antares Pharma, Inc. | 1 | $50 |
| Endo USA, Inc. | 2 | $44 |
| Astellas Pharma US Inc | 1 | $38 |
| Ferring Pharmaceuticals Inc. | 1 | $36 |
| Dendreon Pharmaceuticals LLC | 1 | $27 |
| Progenics Pharmaceuticals, Inc. | 1 | $24 |
| Urovant Sciences Inc | 1 | $20 |
| AbbVie | 1 | $18 |
| Novartis | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$84,716 in reported general payments places this provider in the 95th percentile of 935 urology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other urology in Miami
- Mark Anthony GonzalgoMiami$1M
- Daniel MartinezMiami$133K
- Sanoj PunnenMiami$48K
- Ahmed EldefrawyMiami$47K
- Bruce KavaMiami$44K
- Paul PeritoCoral Gables$3.6M
- Scott SellingerTallahassee$2.3M
- Edward GheilerHialeah$655K
- Rolando RiveraNaples$437K
- Matthew ErcolaniVenice$416K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.